A New Clinical Tool for Gait Evaluation in Parkinsonʼs Disease
- 1 June 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 20 (3) , 183-194
- https://doi.org/10.1097/00002826-199706000-00001
Abstract
This study was devised to check the feasibility and validity of a rating scale specifically designed to evaluate gait impairment in Parkinson's disease (RSGE). Demographic data, a brief questionnaire on general aspects influencing gait and mobility, a battery of scales (Barthel Index; Hoehn and Yahr staging; and Northwestern University Disability, Schwab and England, and Unified Parkinson's Disease. Rating Scale [UPDRS]), and timed tests (“Up and Go” and “Steps X Seconds” tests) were recorded under protocol, as was the RSGE-Version 1.0 (23 items in four subscales). Fifty patients enrolled at two centers were included. Twenty-five (50%) were simultaneously (though independently) evaluated by three examiners, in order to determine the interrater reliability. The mean age of the patients was 67.6 ± 11.16 years, with a mean 8.18 ± 5.58 years of disease duration. Motor fluctuations were present in 48% of patients. The RSGE Cronbach's alpha was 0.94. Only the item “Dyskinesias” was not correlated with the RSGE total sum. The item “Axial rigidity” showed a fair interrater reliability (k = 0.30). However, most of the RSGE items (16/23, 70%) had k ≥0.65. The convergent validity with the applied scales was very high (Spearman r = 0.74–0.90, pKeywords
This publication has 0 references indexed in Scilit: